ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 146 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $302 | -19.7% | 100,700 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $376 | -60.6% | 100,700 | -64.7% | 0.00% | +100.0% |
| Q1 2023 | $954 | +55.1% | 285,600 | +123.3% | 0.00% | -66.7% |
| Q4 2022 | $615 | -99.9% | 127,900 | +40.4% | 0.00% | +50.0% |
| Q3 2022 | $518,000 | -23.1% | 91,100 | -4.1% | 0.00% | -33.3% |
| Q2 2022 | $674,000 | -24.5% | 95,000 | -23.2% | 0.00% | 0.0% |
| Q1 2022 | $893,000 | +1.9% | 123,700 | +26.2% | 0.00% | 0.0% |
| Q4 2021 | $876,000 | -33.9% | 98,000 | +159.3% | 0.00% | -40.0% |
| Q3 2021 | $1,325,000 | +66.5% | 37,800 | +1.9% | 0.01% | +66.7% |
| Q2 2021 | $796,000 | +57.3% | 37,100 | +352.4% | 0.00% | +50.0% |
| Q1 2021 | $506,000 | +246.6% | 8,200 | +134.3% | 0.00% | +100.0% |
| Q4 2020 | $146,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |